Literature DB >> 26303992

Adherence to Ivacaftor is suboptimal.

Janice Abbott1, Diana Bilton2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26303992     DOI： 10.1016/j.jcf.2015.08.001

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN： 1569-1993            Impact factor:   5.482


× No keyword cloud information.
  2 in total

1.  Accurate reporting of adherence to inhaled therapies in adults with cystic fibrosis: methods to calculate "normative adherence".

Authors:  Zhe Hui Hoo; Rachael Curley; Michael J Campbell; Stephen J Walters; Daniel Hind; Martin J Wildman
Journal:  Patient Prefer Adherence       Date:  2016-05-23       Impact factor: 2.711

2.  Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis.

Authors:  Heledd H Jarosz-Griffiths; Thomas Scambler; Chi H Wong; Samuel Lara-Reyna; Jonathan Holbrook; Fabio Martinon; Sinisa Savic; Paul Whitaker; Christine Etherington; Giulia Spoletini; Ian Clifton; Anil Mehta; Michael F McDermott; Daniel Peckham
Journal:  Elife       Date:  2020-03-02       Impact factor: 8.140
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.